Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

Published:2018-02-22 Issue:3 Volume:7 Page:690-697
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Rosner Samuel¹,Kwong Erica²,Shoushtari Alexander N.³⁴,Friedman Claire F.³⁴,Betof Allison S.³,Brady Mary Sue³,Coit Daniel G.³,Callahan Margaret K.³⁴,Wolchok Jedd D.³⁴⁵,Chapman Paul B.³⁴,Panageas Katherine S.³,Postow Michael A.³⁴^ORCID

Affiliation:

1. Department of Medicine; Johns Hopkins Bayview Medical Center; Baltimore Maryland

2. City University of New York at Hunter College; New York City New York

3. Memorial Sloan Kettering Cancer Center; New York City New York

4. Weill Cornell Medical College; New York City New York

5. Ludwig Center for Cancer Immunotherapy; New York City New York

Funder

National Institutes of Health

Conquer Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference29 articles.

1. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N. Engl. J. Med.,2013

2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N. Engl. J. Med.,2015

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma;Larkin;N. Engl. J. Med.,2015

4. Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma;Daud;J. Clin. Oncol.,2016

5. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients;Herbst;Nature,2014

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Evidence for a Causal Relationship Between Innate Leukocytes and the Risk of Digestive System Cancers in East Asians and Europeans;World Journal of Oncology;2024-06

2. IL3-Driven T Cell–Basophil Crosstalk Enhances Antitumor Immunity;Cancer Immunology Research;2024-05-10

3. Eosinophilic granulocytes as a potential prognostic marker for cancer progression and therapeutic response in malignant melanoma;Frontiers in Oncology;2024-05-02

4. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study;Acta Dermato-Venereologica;2024-04-24

5. Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery;Journal of Hepatocellular Carcinoma;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3